ArticleCureus2026
Use of an Amorphous Silica-Based Fiber Wound Matrix and Cream in a Post-Mohs Defect of the Dorsal Hand: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative defects of the dorsal hand following Mohs micrographic surgery may present wound-management challenges because of limited soft-tissue coverage, underlying tendon exposure, mobility, and the potential for functional impairment. We report the clinical course of a 53-year-old patient who underwent Mohs surgery for a biopsy-confirmed keratoacanthoma of the dorsal hand. Following complete removal of the lesion, the surgical defect was managed by secondary intention. Initial postoperative management consisted of Puracol Plus and petrolatum, with granulation coverage of an exposed tendon anticipated within approximately seven weeks. The patient subsequently received an amorphous silica-based fiber (SBF) wound matrix and silica-based cream (SBC) from SiOxMed for home-based self-treatment. SBF was applied daily to the open wound following daily rinsing and reapplication until the wound surface was covered and dry. Serial patient-generated photographs demonstrated granulation tissue covering the previously exposed tendon by Day 26, substantial wound contraction and developing epithelial coverage by Day 45, and complete visible wound coverage by Day 50. SBC was initiated after epithelial coverage was established. A final photograph obtained on Day 118 demonstrated sustained wound closure. This single uncontrolled case cannot establish that SBF or SBC accelerated healing compared with conventional secondary-intention management. However, the observed progression from a postoperative defect with an exposed tendon to granulation coverage, contraction, epithelialization, and sustained closure supports prospective evaluation of this treatment approach in complex postoperative wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.